Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesLung Neoplasms
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
40 – 74
Sex
Any
Study type
Interventional
Purpose
Screening
Participants needed
16,000 (estimated)
Sponsor
The First Affiliated Hospital of Guangzhou Medical University · Other
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Low-dose CT (LDCT)can detect and treat lung cancer earlier and more quickly, while expanded screening coverage helps reduce the incidence and mortality of respiratory diseases such as lung cancer. This study aims to conduct a single-arm cluster randomized trial of digitally enabled LDCT in Guangzhou to assess its intervention effectiveness and cost-effectiveness.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
1.Community Health Service Centers (Cluster Level)
1. Inclusion Criteria The community health service center must be located within one of the 11 districts of Guangzhou.
The center must manage a population of over 10,000 elderly individuals. The center should be equipped with at least one CT ma…
1.Community Health Service Centers (Cluster Level)
1. Inclusion Criteria The community health service center must be located within one of the 11 districts of Guangzhou.
The center must manage a population of over 10,000 elderly individuals. The center should be equipped with at least one CT machine and have qualified medical personnel, such as radiologists, radiologic technicians, and nursing staff.
2. Exclusion Criteria Community health centers currently participating in other public health projects or studies that may affect screening results.
Community health service centers where researchers cannot collect data or conduct follow-up.
2\. Screening Subjects (Individual Level)
1. Inclusion Criteria Aged 40-75 years. Residing in the community participating in the study for a long time. No known history of lung cancer and has not undergone lung cancer screening in the past three months.
Able to understand and willing to sign the informed consent form, and able to participate in long-term follow-up.
2. Exclusion Criteria Individuals diagnosed with lung cancer. Individuals with severe other health issues that make them unsuitable for CT imaging.
Individuals unable to understand the study protocol or who cannot provide informed consent due to cognitive impairments.
Individuals participating in other clinical trials that may affect the results of this study.
Individuals unable to undergo follow-up.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.